期刊文献+

医院抗菌药物使用强度分析 被引量:140

Antibacterial Use Density in a Hospital
原文传递
导出
摘要 目的分析某医院抗菌药物使用情况,为合理使用抗菌药物提供参考依据。方法回顾性收集该院2004~2008年抗菌药物使用记录,采用Excel2003进行统计;以限定日剂量(DDD)为单位,计算抗菌药物使用强度(AUD)并进行分析。结果该院AUD 5年间波动较大;三代头孢、青霉素类+酶抑制剂和二代头孢排名AUD前3位;排名AUD前10位的药品均来自于头孢菌素类、青霉素类+酶抑制剂、硝咪唑类和喹诺酮类,绝大多数都是注射剂;国内外医院的比较显示,该院AUD显著低于我国平均水平,与韩国和美国用药存在较大差异。结论该院可能存在用药过度、用药集中、广谱抗菌药物的使用率高等问题;应严格限制头孢菌素类、青霉素类+酶抑制剂和喹诺酮类的临床应用,避免AUD的过快增长。 OBJECTIVE To provide an evidence for rational use of antibacterials in the clinic through analysis of the antibacterial use in a hospital.METHODS By retrospective study,the data of drug used from 2004 to 2008 were collected and analyzed by Excel 2003.Taking defined daily dose(DDD) as the unit,antibacterial use density(AUD) was calculated and carried on the analysis.RESULTS The AUD was fluctuant during the last 5 years.The third generation cephalosporins,penicillin/beta-lactamase inhibitors and the second generation cephalosporins ranked in the first three places in turn.The drug ranking in the first ten places came from cephalosporins,penicillin/beta-lactamase inhibitors,nitromidazoles,and fluoroquinolones and the majority of antibacterials were injection.Comparing with the domestic and foreign hospital,AUD in the hospital was significantly lower than the average level of China's.The use of antibacterials was different from South Korea and America.CONCLUSIONS The hospital may exist such problems as overmedication,dense medication and the high use ratio of broad-spectrum antimicrobial agents.Cephalosporins,penicillin/beta-lactamase inhibitors and fluoroquinolones should be strictly limited in the clinic to avoid an excessive increase in AUD.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第6期848-851,共4页 Chinese Journal of Nosocomiology
关键词 抗菌药物 限定日剂量 使用强度 用药分析 Antibacterials Defined daily dose Antibacterial use density Drug analysis
  • 相关文献

参考文献18

  • 1孟黎辉,郑佳,李婷.抗菌药物应用调查的量化评估与分析[J].中国感染控制杂志,2006,5(4):330-332. 被引量:20
  • 2任南,文细毛,吴安华.165所医院住院患者抗菌药物临床应用横断面调查[J].中国医师杂志,2007,9(5):633-635. 被引量:38
  • 3肖永红,王进,赵彩云,高磊,郑波,薛峰,李湘艳,郝凤兰,代表Mohnarin协作组.2006-2007年Mohnarin细菌耐药监测[J].中华医院感染学杂志,2008,18(8):1051-1056. 被引量:607
  • 4安丽青,刘卓拉,段金菊,刘建国,张素萍,刘丽华,刘剑俐,张六平.2001-2005年医院感染病原菌及其耐药性变迁分析[J].中华医院感染学杂志,2009,19(4):439-442. 被引量:13
  • 5World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC classification and DDD assignment [EB/OL]. Available at: http:// www. whoce. no/atcddd.
  • 6Meyer E, Jonas D, Schwab F,et al. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units[J]. Infection, 2003,31 (4): 208-215.
  • 7冯霞,张春梅,钟艺.我院2000年~2004年抗菌药物利用分析[J].中国医院用药评价与分析,2005,5(6):358-361. 被引量:10
  • 8Kim JY, Sohn JW, Park DW, et al. Control of extended spectrum (3-1actamase-produeing Klebsiella pneumoniae using a computer assisted management program to restrict third-generation eephalosporin use[J]. J Antimicrob Chemother,2008, 62(2):416-421.
  • 9Polk RE, Fox C, Mahoney A,etal. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy[J]. Antibiot Measurements, 2007,44 (5): 664-669.
  • 10Pakyz A,Powell JP, Harpe SE, etal. Diversity of antimicrobial use and resistance in 42 hospitals in the United States[J]. Pharmacotherapy, 2008,28(7) : 906-912.

二级参考文献115

共引文献911

同被引文献852

引证文献140

二级引证文献678

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部